LakeShore Biopharma Co., Ltd (LSB)

LakeShore Biopharma Revenue

In the fiscal year ending March 31, 2025, LakeShore Biopharma had annual revenue of 614.96M CNY with 7.24% growth. LakeShore Biopharma had revenue of 135.35M in the quarter ending March 31, 2024, with 27.67% growth.

• Revenue (ttm): 614.96M CNY
• Revenue Growth: -6.54%
• P/S Ratio: 0.19
• Revenue / Employee: 1,073,231 CNY
• Employees: 573
• Market Cap: 33.79M undefined

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	614.96M	41.54M	7.24%
Mar 31, 2024	573.42M	-113.78M	-16.56%
Mar 31, 2023	687.20M	184.25M	36.63%
Mar 31, 2022	502.95M	245.93M	95.69%
Mar 31, 2021	257.02M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.